Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
1999
Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study
2011
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival
2010
Pancreatic cancer
2004 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy
2007
Cancer‐specific survival after radical cystectomy and standardized extended lymphadenectomy for node‐positive bladder cancer: prediction by lymph node positivity and density
2009
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Erectile Dysfunction
2000 Standout
Permutation tests for joinpoint regression with applications to cancer rates
2000 Standout
Marine natural products
1990 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
2005
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
2008 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents
2014
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure
2006
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
2014 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma
2015
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
2009
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Urothelial Carcinoma of the Prostate
2007
Future strategies in the diagnosis, staging and treatment of bladder cancer
2003
A molecular signature of metastasis in primary solid tumors
2002 Standout
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
2014
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Mice lacking tartrate‐resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus
2001 StandoutNobel
Treatment of Patients with Cancer of an Unknown Primary Site
1993
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs
2006
Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease
2008
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
The Role of New Modalities in the Early Detection and Diagnosis of Prostate Cancer
1989
A Review of Integrated Staging Systems for Renal Cell Carcinoma
2012
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
2014
Anatomic Basis for Lymph Node Counts as Measure of Lymph Node Dissection Extent: A Cadaveric Study
2013
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Connections with Connexins: the Molecular Basis of Direct Intercellular Signaling
1996 Standout
Sexual function in spinal cord lesioned men
2001
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
2012
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
2018
Genomics: a preview of genomic medicine
2008
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Interleukin-8 and human cancer biology
2001
Small Renal Mass
2010
Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
2008
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
DIABETIC SEXUAL DYSFUNCTION
1996
Targeting Recovery: Priorities of the Spinal Cord-Injured Population
2004 Standout
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
2012
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
INTRACAVERNOUS INJECTION THERAPY FOR MALE ERECTILE DYSFUNCTION
1995
Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies
2013
The Chromophobe Tumor Grading System is the Preferred Grading Scheme for Chromophobe Renal Cell Carcinoma
2011
Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis
2002
AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated fromAndrographis paniculata
2013
Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
2008
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
1996
The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.
1985
BILATERAL EXTRAVESICAL URETERAL REIMPLANTATION IN TOILET TRAINED CHILDREN: IS 1-DAY HOSPITALIZATION WITHOUT URINARY RETENTION POSSIBLE?
2005
Bladder Cancer
2020 Standout
Impact of the Extent of Regional Lymphadenectomy on the Survival of Patients With Urothelial Carcinoma of the Upper Urinary Tract
2007
Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus
2007
Long-Term Outcomes After Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm
2008
Pharmacology of Penile Erection
2001
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
The Mainz Classification of Renal Cell Tumors
1999
Prostatic Acid Phosphatase: Its Current Clinical Status
1987
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium
2006
PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPING
2004
Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma
1997
Promotion of IL-8 production in PMA-stimulated HL-60 cells by sesquiterpene quinones from a marine sponge, Hippospongia sp.
2007
The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
2009 Standout
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Renal Tumor Biopsies for Evaluation of Small Renal Tumors: Why, in Whom, and How?
2008
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Gap junction-mediated intercellular diffusion of Ca2+ in cultured human corporal smooth muscle cells
1992
Outcomes Following Partial Nephrectomy by Tumor Size
2008
Biomedical Importance of Indoles
2013 Standout
The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis.
1998
Diabetic Autonomic Neuropathy
2003 Standout
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
2017
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Immunocytochemical Localisation of Prostate‐specific Antigen: Specificity and Application to Clinical Practice
1985
Works of E. P. Allhoff being referenced
Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma.
1993
Pathobiology and prognosis of chromophobe renal cell carcinoma
2008
Die therapeutische Wertigkeit der ambulanten extrakorporalen Stoßwellenlithotripsie von Speichelsteinen. Ergebnisse einer prospektiven Studie
1993
Evaluation of peri‐operative peripheral and renal venous levels of pro‐ and anti‐angiogenic factors and their relevance in patients with renal cell carcinoma
2007
Stage I Seminoma of the Testis. Adjuvant Radiotherapy or Surveillance?
1991
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer
2003
Metastatic renal cell carcinoma (RCC): Spontaneous regression, long-term survival and late recurrence
1991
Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer
2005
Spontaneous Regression of Metastatic Renal Carcinoma with Long‐term Survival
1991
THE PELVIC PLEXUS AND ANTIREFLUX SURGERY: TOPOGRAPHICAL FINDINGS AND CLINICAL CONSEQUENCES
2001
Complete spontaneous regression in metastatic renal cell carcinoma — an update and review
1991
Refluxing Ureterointestinal Anastomosis for Continent Cutaneous Urinary Diversion
2002
Single Potential Analysis of Cavernous Electrical Activity in Impotent Patients: A Possible Diagnostic Method for Autonomic Cavernous Dysfunction and Cavernous Smooth Muscle Degeneration
1991
Evaluation of Prostate Specific Acid Phosphatase and Prostate Specific Antigen in Identification of Prostatic Cancer
1983
Prostate-specific antigen—comparative clinical appreciation of a serodiagnostic measure after 8 years of experience
1989
Current clinical relevance of immunotherapy in metastatic renal cell cancer
1991
Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas
2008
Loss of Heterozygosity on Chromosome 5p13-12 Predicts Adverse Prognosis in Advanced Bladder Cancer Independent of Tumor Stage and Grade
2002
Die Bedeutung der pelvinen Lymphadenektomie für die Prognose nach radikaler Zystektomie
2002
Single potential analysis of cavernous electric activity —a possible diagnosis of autonomic impotence?
1990
Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivo
1991
Extended Radical Lymphadenectomy in Patients With Urothelial Bladder Cancer:: Results of a Prospective Multicenter Study
2004
The Influence of Anterior Root Stimulation (S2) in Deafferented Spinal Cord Injury Men on Cavernous Electrical Activity
1992
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
1999